Abstract
We report a case of kappa-AL amyloidosis which rapidly developed hepatic failure in a 79-year-old Japanese female who was admitted to our hospital because of abdominal distension and loss of appetite. Laboratory examination revealed a marked deterioration of liver function with cholestasis and monoclonal gammapathy. At the time that the diagnosis of IgG-k type multiple myeloma was made, jaundice was advanced, with continuous gastrointestinal bleeding. The patient died of hepatic failure 2 weeks after admission. Needle biopsy of the liver revealed a diffuse, massive deposition of amyloid protein.
Similar content being viewed by others
References
Levine RA. Amyloid disease of the liver. Correlation of clinical, functional, and morphologic features in 47 patients. Am J Med 1962;33:349–357.
Kyle RA, Bayrd ED. Amyloidosis; review of 236 cases. Medicine 1975;54:271–299.
Levy M, Fryd CH, Eliakim M. Intrahepatic obstructive jaundice due to amyloidosis of the liver. A case report and review of the literature. Gastroenterology 1971;61:234–238.
Calomeni JA, Smith JR. Obstructive jaundice from hepatic amyloidosis in a patient with multiple myeloma. Am J Hematol 1985;19:277–279.
Taylor CR. Immunoperoxidase techniques. Arch Pathol Lab Med 1978;102:113–121.
Mepam BL, Frater N, Mitchell BS. The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique. Histochem J 1979;11:345–357.
Bero GL. Amyloidosis: Its clinical and pathologic manifestations with report of 12 cases. Ann Int Med 1957;46:931–955.
Cohen AS, Skinner M. Amyloidosis of the liver. In: Schiff L, Schiff ER (eds) Diseases of the liver. Philadelphia: Lippincott, 1982;1081–1099.
Chopr S, Rubinow A, Koff RS, et al. Hepatic amyloidosis. A histopathologic analysis of primary (AL) and secondary (AA) forms. Am J Pathol 1984;115:186–193.
Bannick EG, Berkman JM, Beaver DC. Diffuse amyloidosis. Three unusual cases. Arch Intern Med 1933;51:978–990.
Orloff J, Felder L. Primary systemic amyloidosis. Jaundice as a race accompaniment. Am J Med Sci 1946;212:275–279.
Zetzel L. Hepatomegaly with jaundice due to primary amyloidosis, Gastroenterology 1947;8:783–787.
Sanders RJ, Child CG. Primary amyloidosis with jaundice. JAMA 1960;174:1202–1204.
Mir-Madjlessi SH, Farmer RG, Hawk WA. Cholestatic jaundice associated with primary amyloidosis. Cleve Clin Q 1972;39:167–175.
Oliai A, Koff RS. Primary amyloidosis presenting as “sicca complex” and severe intrahepatic cholestasis. Am J Dig Dis 1972;17:1033–1036.
Ashley PF, Brereton RB. Hepatomegaly and jaundice in a 68-year-old woman. Del Med J 1975;46:75–84.
Rollinghoff W, Braun HJ, Schad FJ. Intrahepatische Cholestase als Leitsymptom eine primaren Amyloidose. Dtsch Med Wochenschr 1976;101:1838–1841.
Rubinow A, Koff RS, Cohen AS. Severe intrahepatic cholestasis in primary amyloidosis. Am J Med 1978;64:937–946.
Rubio PA, Farrell EM, Lehan DE. Primary liver amyloidosis producing obstructive jaundice. South Med J 1979;7:891–892.
Bjerrum L, Steiness I, Primary general amyloidosis leading to cholestatic icteus (in Danish). Ugeskn Laeger 1980;142: 1930–1931.
Bengoechea AB, Iribar GI, Urizar JA. Ictericia de causa poco frecuente: amiloidosis hepatica. Med Clin (Barc) 1981;77:393–395.
Finkelstein SD, Fornasier VL, Pruzanski W. Intrahepatic cholestasis with predominant pericentral deposition in systemic amyloidosis. Hum Pathol 1981;12:470–472.
Cox R. Amyloidosis of the liver causing jaundice. Postgrad Med J 1982;58:192–193.
Melato M, Manconi R, Magris D, et al. Different morphologic aspects and clinical features in massive hepatic amyloidosis. Digestion 1984;29:138–145.
Skander MP, Harry DS, Lee FI. Severe intrahepatic cholestasis and rapidly progressive renal failure in a patient with immunocyte related amyloidosis. J Clin Gastroenterol 1987;9:219–222.
Konikoff F, Mor C, Stern S, et al. Cholestasis and liver failure with lambda-AL amyloidosis. Gut 1987;28:903–906.
Joeng HJ, Hahn K, Kim E, et al. Hepatic amyloidosis: Two case reports. J Kor Med Sci 1988;3:151–155.
Dohmen K, Nagano M, Iwakiri R, et al. A case of prominent hepatic cholestasis developing to hepatic failure in lambda-AL amyloidosis. Gastroenterol Jpn 1991;26:376–381.
Levy M, Polliack A, Lender M, et al. The liver in amyloidosis. Digestion 1974;10:40–51.
Pras M, Frangione B, Franklin EC. Isolated giant hepatomegaly—a clinical marker of AL-kappa amyloidosis. In: Glenner GG, e Costa PP, de Freitas AF (eds) Amyloid and amyloidosis. Proc 3rd Int Symposium Amyloidosis. Amsterdam: Excerpta medica, 1979;249–252.
Preud'homme JL, Graneval D, Grünfeld JP, et al. Immunoglobulin synthesis in primary and myeloma amyloidosis. Clin Exp Immunol 1988;73:389–394.
Aramaki T, Terada H, Okamura H, et al. Portal hypertension secondary to intrahepatic arterio-portal shunt in primary amyloidosis: A case report. Gastroenterol Jpn 1989;24:410–413.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yamamoto, T., Maeda, N. & Kawasaki, H. Hepatic failure in a case of multiple myeloma-associated amyloidosis (k-AL). J Gastroenterol 30, 393–397 (1995). https://doi.org/10.1007/BF02347517
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02347517